Amaria, R. N., Kopetz, S., Morelli, M. P., Blumenschein, G. R., Altan, M., Sanber, K., Jazaeri, A. A., Davies, M. A., Diab, A., Glitza, I. C., McQuade, J. L., Ikeguchi, A., Tawbi, H. A., Bernatchez, C., Forget, M., Haymaker, C. L., Wong, K., Tobin, E., Benson, M. J., Truppel-Hartmann, A. (2025). A phase 1/2 study of KSQ-004EX: Autologous tumor infiltrating lymphocytes, engineered to inactivate genes encoding SOCS1 and Regnase-1, in patients with select advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps2675